Melphalan hydrochloride NDC 72266-128

NDC codes

FDA NDC Directory

Product NDC (as listed)72266-128Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72266-0128Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72266-128-01	72266012801	1 KIT in 1 CARTON (72266-128-01) * 10 mL in 1 VIAL, SINGLE-DOSE (72266-144-01) * 10 mL in 1 VIAL, SINGLE-USE (72266-145-01)Marketed from Sep 23, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Melphalan hydrochloride
Generic name (nonproprietary): melphalan hydrochloride
Dosage form: Kit
Labeler: Fosun Pharma USA Inc
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209826
Marketing start: Sep 23, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 72266-128_2b363439-ace2-30e1-e063-6294a90ad47fSPL ID 2b363439-ace2-30e1-e063-6294a90ad47fSPL set ID 54712714-744d-4deb-83b2-694da49a9272RxCUI 311487UPC 0372266128010

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N472266012801 followed by a unit qualifier and the quantity

Package 72266-0128-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 28, 2019. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS & USAGE Melphalan hydrochloride for Injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209826

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209826
Product	Strength	Form · route	Labeler	Product NDC
Melphalan Hydrochloride	—	KitIntravenous	Sagent Pharmaceuticals	25021-258
Melphalan hydrochloride	—	Kit	Gland Pharma Limited	68083-259